Chronic neutrophilic leukemia: Novel mutations and their impact on clinical practice

Current Opinion in Hematology

Volumn 22, Issue 2, 2015, Pages 171-176

  Tefferi, Ayalew ^a   Elliott, Michelle ^a   Pardanani, Animesh ^a  

^a MAYO CLINIC   (United States)

Author keywords

CSF3R; leukemia; neutrophilic

Indexed keywords

COLONY STIMULATING FACTOR 3 RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR; UNCLASSIFIED DRUG; CSF3R PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ATYPICAL CHRONIC MYELOID LEUKEMIA; CANCER DIAGNOSIS; CANCER PROGNOSIS; CHRONIC NEUTROPHILIC LEUKEMIA; CLINICAL PRACTICE; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; GERMLINE MUTATION; HUMAN; MULTICENTER STUDY (TOPIC); NEUTROPHILIA; NONSENSE MUTATION; PRIORITY JOURNAL; REVIEW; SEVERE CONGENITAL NEUTROPENIA; ACUTE MYELOBLASTIC LEUKEMIA; DISEASE MANAGEMENT; GENETICS; LEUKEMIA, NEUTROPHILIC, CHRONIC; MORTALITY; MUTATION; NEUTROPENIA; PROGNOSIS;

DISEASE MANAGEMENT; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, NEUTROPHILIC, CHRONIC; MUTATION; NEUTROPENIA; PROGNOSIS; RECEPTORS, COLONY-STIMULATING FACTOR;

EID: 84923221775     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000114     Document Type: Review

References (25)

1. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114:937-951.
2. Maxson JE, Gotlib J, Pollyea DA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med 2013; 368:1781-1790.
3. Pardanani A, Lasho TL, Laborde RR, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia 2013; 27:1870-1873.
4. Wang SA, Hasserjian RP, Fox PS, et al. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood 2014; 123:2645-2651.
5. Mehta HM, Glaubach T, Long A, et al. Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling. Leukemia 2013; 27:2407-2410.
6. Meggendorfer M, Haferlach T, Alpermann T, et al. Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia. Haematologica 2014; 99:e244-e246.
7. Cui Y, Li B, Gale RP, et al. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia. J Hematol Oncol 2014; 7:77.
8. Menezes J, Makishima H, Gomez I, et al. CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia. Blood Cancer J 2013; 3:e158.
9. Boztug K, Klein C. Genetic etiologies of severe congenital neutropenia. Curr Opin Pediatr 2011; 23:21-26.
10. Triot A, Jarvinen PM, Arostegui JI, et al. Inherited biallelic CSF3R mutations in severe congenital neutropenia. Blood 2014; 123:3811-3817.
11. Vandenberghe P, Beel K. Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS. Pediatr Rep 2011; 3 (Suppl 2):e9.
12. Germeshausen M, Ballmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood 2007; 109:93-99.
13. Bernard T, Gale RE, Evans JP, Linch DC. Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. Br J Haematol 1998; 101:141-149.
14. Bernard T, Gale RE, Linch DC. Analysis of granulocyte colony stimulating factor receptor isoforms, polymorphisms and mutations in normal haemopoietic cells and acute myeloid leukaemia blasts. Br J Haematol 1996; 93:527-533.
15. Forbes LV, Gale RE, Pizzey A, et al. An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. Oncogene 2002; 21:5981-5989.
16. Plo I, Zhang Y, Le Couedic JP, et al. An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia. J Exp Med 2009; 206:1701-1707.
17. Beekman R, Valkhof MG, Sanders MA, et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 2012; 119:5071-5077.
18. Beekman R, Valkhof M, van Strien P, et al. Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia. Haematologica 2013; 98:e62-e63.
19. Fleischman AG, Maxson JE, Luty SB, et al. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition. Blood 2013; 122:3628-3631.
20. Maxson JE, Luty SB, MacManiman JD, et al. Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization. J Biol Chem 2014; 289:5820-5827.
21. Dao KH, Solti MB, Maxson JE, et al. Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia. Leukemia Res Rep 2014; 3:67-69.
22. Lasho TL, Mims A, Elliott MA, et al. Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib. Leukemia 2014; 28:1363-1365.
23. Kosmider O, Itzykson R, Chesnais V, et al. Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia. Leukemia 2013; 27:1946-1949.
24. Elliott MA, Tefferi A. Chronic neutrophilic leukemia 2014: update on diagnosis, molecular genetics, and management. Am J Hematol 2014; 89:651-658.
25. Langabeer SE, McCarron SL, Haslam K, et al. The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT. Bone Marrow Transplant 2014; 49:843-844.